Home Cart 0 Sign in  
X

[ CAS No. 254454-54-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 254454-54-1
Chemical Structure| 254454-54-1
Chemical Structure| 254454-54-1
Structure of 254454-54-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 254454-54-1 ]

Related Doc. of [ 254454-54-1 ]

Alternatived Products of [ 254454-54-1 ]

Product Details of [ 254454-54-1 ]

CAS No. :254454-54-1 MDL No. :MFCD09752821
Formula : C8H14INO2 Boiling Point : -
Linear Structure Formula :- InChI Key :XPDIKRMPZNLBAC-UHFFFAOYSA-N
M.W : 283.11 Pubchem ID :11000522
Synonyms :
Chemical Name :tert-Butyl 3-iodoazetidine-1-carboxylate

Calculated chemistry of [ 254454-54-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.88
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 59.94
TPSA : 29.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.69 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.62
Log Po/w (XLOGP3) : 1.89
Log Po/w (WLOGP) : 1.66
Log Po/w (MLOGP) : 1.71
Log Po/w (SILICOS-IT) : 1.43
Consensus Log Po/w : 1.86

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.59
Solubility : 0.731 mg/ml ; 0.00258 mol/l
Class : Soluble
Log S (Ali) : -2.13
Solubility : 2.09 mg/ml ; 0.00737 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.66
Solubility : 6.17 mg/ml ; 0.0218 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.25

Safety of [ 254454-54-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P271-P280-P261-P302+P352-P305+P351+P338-P304+P340-P312-P362+P364-P403+P233-P501 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 254454-54-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 254454-54-1 ]
  • Downstream synthetic route of [ 254454-54-1 ]

[ 254454-54-1 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 254454-54-1 ]
  • [ 147621-21-4 ]
Reference: [1] Synlett, 1998, # 4, p. 379 - 380
  • 2
  • [ 141699-55-0 ]
  • [ 254454-54-1 ]
YieldReaction ConditionsOperation in experiment
99% With 1H-imidazole; iodine; triphenylphosphine In toluene at 100℃; for 1 h; STAP B tert-butyl 3-iodoazetidine- 1 -carboxylate. [Chem.10][0206] To a solution of tert-butyl 3-hydroxyazetidine-l-carboxylate (3.35 g, 19.3 mmol) in toluene (200 mL) was added imidazole (3.95 g, 58.0 mmol), triphenylphosphine (10.1 g, 38.7 mmol) and iodine (7.36 g, 29.0 mmol). The mixture was heated for 1000C for Ih, cooled to room temperature, then poured into sodium bicarbonate aqueous solution (30 mL). Excess triphenylphosphine was destroyed by addition of iodine until iodine coloration persisted in organic layer. The organic layer was separated and washed with saturated sodium thiosulfate aqueous solution, dried over sodium sulfate. The crude product was purified by silica gel column chromatography (hexane - ethyl acetate = 9:1 to 1:1) to gave the title compound (5.42 g, 99percent) as clear oil.[0207] MS (ESI) m/z 284 (M+ 1)+.
95% With 1H-imidazole; iodine; triphenylphosphine In toluene at 100℃; for 1 h; A solution of 3-hydroxy-azetidine-i-carboxylic acid tert-butyl ester (3.35 g, 19.34 mmol) in toluene (200 ml) was treated with imidazole (3.95 g, 58.01 mmol), triphenyl- phosphine (10.14 g, 38.65 mmol) and I2 (7.36 g, 28.99 mmol). The mixture was heated at 1000C for 1 h, cooled down to room temperature and next poured into saturated aqueous NaHCO3 (30 ml). Excess triphenylphosphine was destroyed by addition of iodine until I2 coloration persisted in organic layer. The latter was washed with 5percent aqueous Na2S2O3, dried over Na2SO4 and evaporated. Purification of the crude product by flash column chromatography (heptane:ethyl acetate, 2:1) provides the title com.not. pound (5.19 g, 95percent) as a light yellow oil. MS (ESI+) m/z = 227.9 [M-ffiu+H]+ 1H NMR (400 MHz, CDCI3) : δ (ppm) 1.44 (s, 9H), 4.29 (dd, J = 10.4, 5.4 Hz, 2H), 4.47 (m, 1 H), 4.64 (dd, J = 9.5, 8.0 Hz, 2H).
95%
Stage #1: With 1H-imidazole; iodine; triphenylphosphine In toluene at 100℃; for 1 h;
Stage #2: With sodium hydrogencarbonate In water; toluene
A solution of 3-hydroxy-azetidine-1-carboxylic acid tert-butyl ester (3.35 g, 19.34 mmol) in toluene (200 ml) was treated with imidazole (3.95 g, 58.01 mmol), triphenyl- phosphine (10.14 g, 38.65 mmol) and I2 (7.36 g, 28.99 mmol). The mixture was heated at 1000C for 1 h, cooled down to room temperature and subsequently poured into a saturated aqueous solution of NaHCO3 (30 ml). Excess triphenylphosphine was destroyed by addition of iodine until b coloration persisted in organic layer. The latter was washed with an aqueous solution of Na2S2ψ3 (5 percent strength), dried over Na2SU4, filtered and concentrated in vacuo. Purification of the residue by flash column chromatography (heptane: EtOAc, 2:1 ) provides the title compound (5.19 g, 95 percent) as a light yellow oil.MS (ESI+) : m/z = 227.9 [M-tBu+H]+ ; 1H-NMR (400 MHz, CDCI3) : δ = 1.44 (s, 9H), 4.29 (dd, J = 10.4, 5.4 Hz, 2H), 4.47 (m, 1 H), 4.64 ppm (dd, J = 9.5, 8.0 Hz, 2H).
93% With 1H-imidazole; iodine; triphenylphosphine In toluene at 100℃; for 1 h; A solution of ieri-butyl 3-hydroxyazetidine-l-carboxylate (25-3) (3.5 g, 0.02 mol) in toluene (200 mL) was treated with imidazole (4.08 g, 0.06 mol), PPh3 (0.6 g, 0.04 mol), and I2 (7.62 g, 0.03 mol). The mixture was heated at 100°C for 1 h and cooled down to room temperature. It was then poured into saturated NaHCC^ solution (30 mL). Excess PPh3 was destroyed by addition of iodine until I2 coloration persisted in organic layer. The mixture was washed with 5percent Na2SC>3 solution, dried over Na2S04, and evaporated in vacuo. The residue was purified on silical gel column to give 199a (5.31 g, 93percent). MS: [M+H]+ 284.
93% With 1H-imidazole; iodine; triphenylphosphine In toluene at 100℃; for 1 h; Example 206a
tert-Butyl 3-Iodoazetidine-1-carboxylate 206a
A solution of tert-butyl 3-hydroxyazetidine-1-carboxylate (3.5 g, 0.020 mol) in toluene (200 mL) was treated with imidazole (4.08 g, 0.060 mol), triphenylphosphine (0.60 g, 0.040 mol), and iodine (7.62 g, 0.030 mol).
The mixture was heated at 100°C for 1 h.
It was then cooled to room temperature and poured into saturated NaHCO3 solution (30 mL).
Excess triphenylphosphine was destroyed by addition of iodine until iodine coloration persisted in organic layer.
The mixture was washed with 5percent Na2SO3 solution, dried over Na2SO4, and evaporated in vacuo.
The residue was purified by silica-gel column chromatography to afford 206a (5.31 g, 93percent). MS-ESI: [M+H]+284.
91% With 1H-imidazole; iodine; triphenylphosphine In toluene at 110℃; for 4 h; To a solution of tert-butyl 3-hydroxyazetidine-1-carboxylate (400 mg, 2.31 mmol) in toluene (23 ml), imidizole (472 mg, 6.93 mmol), triphenylphosphine (1.21 g, 4.62 mmol) and iodine (879 mg, 3.46 mmol) were added successively and the reaction mixture was heated at 110° C. for 4 h.
The cooled reaction mixture was quenched with saturated aqueous NaHCO3 and extracted with Et2O (2*).
The Et2O layers were combined and the composite was treated with iodine until a persistent brown color occurred and the mixture was stirred at RT overnight.
The Et2O solution was treated with saturated aqueous Na2S2O3 until colorless, the phases were split and the organic phase was dried over MgSO4, filtered and concentrated under reduced pressure.
The residue was purified by silica gel chromatography eluting with 0 to 20percent EtOAc in hexane to give Compound 9a (594 mg, 91percent yield) as a clear colorless oil. MS m/z=284.0, (M+H) 1H NMR (CHLOROFORM-d) δ: 4.57 (t, J=8.4 Hz, 2H), 4.36-4.44 (m, 1H), 4.18-4.26 (m, 2H), 1.37 (s, 9H).
3.23 g With 1H-imidazole; iodine; triphenylphosphine In toluene at 100℃; for 1.75 h; (1) To a solution of Compound 1 (2.0 g) in toluene (115 mL) was added imidazole (2.36 g), triphenylphosphine (6.06 g), and iodine (4.4 g), and the mixture was stirred at 100°C for 1 hour and 45 minutes. The reaction mixture was cooled to room temperature, a saturated aqueous solution of sodium hydrogen carbonate was added thereto, stirred, then iodine was added thereto, stirred, and extracted with ethyl acetate. The resultant organic layer was dried, and concentrated under reduced pressure. The residue was purified with silica gel column chromatography (hexane:ethyl acetate=100:0-75:25) to give Compound 2 (3.23 g) as a colorless liquid.

Reference: [1] Patent: WO2010/84767, 2010, A1, . Location in patent: Page/Page column 47
[2] Patent: WO2006/40182, 2006, A1, . Location in patent: Page/Page column 132-133
[3] Patent: WO2008/116831, 2008, A1, . Location in patent: Page/Page column 37
[4] Patent: WO2011/140488, 2011, A1, . Location in patent: Page/Page column 287; 288
[5] Patent: EP2773638, 2015, B1, . Location in patent: Paragraph 0805; 0806
[6] Patent: US2017/275272, 2017, A1, . Location in patent: Paragraph 0908; 0909
[7] Organic Letters, 2014, vol. 16, # 23, p. 6160 - 6163
[8] Journal of Medicinal Chemistry, 2012, vol. 55, # 21, p. 9055 - 9068
[9] Patent: US2014/235614, 2014, A1,
[10] Patent: EP3150578, 2017, A1, . Location in patent: Paragraph 0655
[11] Patent: EP3202765, 2017, A1,
[12] Patent: WO2006/134487, 2006, A1,
  • 3
  • [ 141699-58-3 ]
  • [ 254454-54-1 ]
YieldReaction ConditionsOperation in experiment
84% With potassium iodide In N,N-dimethyl-formamide at 110℃; for 16 h; Potassium iodide (12.9 g, 77.7 mmol) and C6 (6.5 g, 26.0 mmol) were combined in DMF (40 mL).
The reaction mixture was stirred at 110° C. for 16 h, then concentrated in vacuo, diluted with water, and extracted with EtOAc.
The combined organic layers were washed with water, then washed with saturated aqueous sodium chloride solution and dried over magnesium sulfate.
Filtration and removal of solvent in vacuo gave a residue, which was purified by silica gel chromatography (Eluant: 4:1 heptane:EtOAc) to afford C7 as a solid. Yield: 6.2 g, 21.9 mmol, 84percent. LCMS m/z 284.0 (M+1).
1H NMR (400 MHz, CDCl3) δ 1.43 (s, 9H), 4.28 (m, 2H), 4.46 (m, 1H), 4.64 (m, 2H).
13C NMR (100 MHz, CDCl3) δ 2.57, 28.27, 61.49, 80.09, 155.52.
83% With potassium iodide In N,N-dimethyl-formamide at 110℃; for 16 h; Tert-butyl 3-((methylsulfonyl)oxy)azetidin-1-carboxylate (2.67 g, 10.62 mmol) was dissolved in 20mL N,N-dimethyl formamide, and potassium iodide (5.3 g, 31.93 mmol) was added.
The resultant mixture was heated to 110°C and reacted for 16 h.
After the reaction, the solvent was removed by rotary evaporation, and 50mL water was added.
After extraction with ethyl acetate (3*30mL), the organic phases were combined, dried with anhydrous sodium sulphate, and filtrated.
The solvent was removed by rotary evaporation, and the residue was subjected to silica gel column chromatography (petroleum ether: ethyl acetate=4:1) to obtain the product (2.5g, yield: 83percent).
72% With potassium iodide In N,N-dimethyl-formamide at 110℃; for 7 h; Preparation 58 tert-Butyl 3-iodoazetidine-i-carboxylate; tert-Butyl 3-(methylsulfonyloxy)azetidine-1-carboxylate (Preparation 57, 8Og, 0.318 mol) and potassium iodide (159g, 0.96 mol) were mixed in dimethylformamide (500 ml_). The reaction mixture was stirred at 11O0C for 7 hours. The solvent was evaporated and the resulting residue was suspended in water (1 L). The product was extracted with ethyl acetate (80OmL). The combined extracts were washed with water, dried using anhydrous sodium sulfate and concentrated in vacuo. The residue was purified by column chromatography on silica gel eluting with ethyl acetate: hexane (1 :4) to afford the title compound (64.6 g, 72percent). 1H NMR (400 MHz, DMSOd6): δ = 1.38 (s, 9H), 4.05-4.09 (m, 2H), 4.61-4.64 (m, 3H) ppm.
68% With potassium iodide In dimethyl sulfoxide at 140℃; for 2 h; Inert atmosphere Production Example 26-3
tert-Butyl 3-iodoazetidine-1-carboxylate
Potassium iodide (51.0 g, 307 mind) was added to a solution of tert-butyl 3-((methylsulfonyl)oxy)azetidine-1-carboxylate described in Production Example 26-2 (7.72 g, 30.7 mmol) in dimethylsulfoxide (80 mL) under nitrogen atmosphere at room temperature, and the mixture was stirred at 140° C. for 2 hours.
The reaction liquid was diluted with diethyl ether and water.
The aqueous layer was extracted with diethyl ether.
The combined organic layer was washed serially with an aqueous sodium pyrosulfite solution and a saturated saline solution and then dried over anhydrous sodium sulfate.
The drying agent was separated by filtration and then the resultant was concentrated under vacuum.
The residue was purified with silica gel column chromatography (n-heptane:ethyl acetate 9:1-1:1) to obtain the title compound (5.91 g, 68percent).
1H-NMR Spectrum (CDCl3) δ (ppm): 1.44 (9H, s), 4.25-4.33 (2H, m), 4.42-4.51 (1H, m), 4.61-4.69 (2H, m).

Reference: [1] Patent: US2010/190771, 2010, A1, . Location in patent: Page/Page column 11-12
[2] Journal of Medicinal Chemistry, 2012, vol. 55, # 21, p. 9055 - 9068
[3] Patent: EP3202765, 2017, A1, . Location in patent: Paragraph 0218; 0219
[4] Synlett, 1998, # 4, p. 379 - 380
[5] Patent: WO2010/131145, 2010, A1, . Location in patent: Page/Page column 77
[6] Patent: US2014/235614, 2014, A1, . Location in patent: Paragraph 0573; 0574; 0575
[7] Patent: US2003/83228, 2003, A1,
[8] Patent: US2003/105114, 2003, A1,
[9] Patent: US2001/44434, 2001, A1,
[10] Patent: US2003/162782, 2003, A1,
[11] Patent: US2002/173502, 2002, A1,
[12] Patent: US2002/22732, 2002, A1,
[13] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 5, p. 1517 - 1521
[14] Patent: EP1176147, 2002, A1, . Location in patent: Page 25
  • 4
  • [ 141699-58-3 ]
  • [ 254454-54-1 ]
YieldReaction ConditionsOperation in experiment
60% With potassium iodide In dimethyl sulfoxide; pentane Preparation 32
1- tert -Butyloxycarbonyl-3-iodoazetidine
A mixture of 1-tert-butyloxycarbonyl-3-(methylsulfonyloxy)azetidine (Preparation 31) (28g, 111mmol) and potassium iodide (170g, 1.02mol) in dimethylsulphoxide (250ml) was heated to 140°C and stirred for 2 hours.
The reaction mixture was cooled, poured into water (1000ml) and extracted with diethyl ether (x2).
The combined organic layers were washed with an aqueous solution of sodium metabisulfite, brine, dried over Na2SO4, filtered and solvent removed under reduced pressure.
The residue was purified by column chromatography on silica gel, eluding with a solvent system of ethyl acetate: pentane (1:1, by volume) to give the title compound as a pale yellow oil (19g, 60percent).
1H-NMR (CDCl3): δ = 4.65 (2H, m), 4.50 (1H, m), 4.30 (2H, m), 1.45 (9H, s).
Reference: [1] Patent: EP992493, 2000, A1,
  • 5
  • [ 916899-83-7 ]
  • [ 254454-54-1 ]
Reference: [1] Patent: WO2006/134487, 2006, A1, . Location in patent: Page/Page column 41
  • 6
  • [ 19540-05-7 ]
  • [ 24424-99-5 ]
  • [ 254454-54-1 ]
YieldReaction ConditionsOperation in experiment
5.8 g With sodium iodide In tetrahydrofuran; dibutyl ether; acetonitrile at -78 - 24℃; To a flame-dried 500 mL round bottom flask was added 1-amino-2,3-dibromopropane hydrobromide (17) (7.5 g, 0.025 mol, 1 equiv.) and stirred without solvent to obtain 17 asa fine powder under argon (alternatively, crystals of 17 could be ground to a fine powder by hand before use).Dry THF (75 mL) was added to the flask and cooled to –78 oC. PhLi solution (1.8M in dibutyl ether, 39.8 mL,0.075 mol, 3 equiv.) was slowly added via syringe and the reaction mixture stirred at –78 oC for 2 h. To theresulting mixture was added MeCN (240 mL), NaI (11.4 g, 0.075 mol, 3 equiv.) and Boc2O (11.2 mL, 0.050 mol,2 equiv.) at –78 oC and warmed at rt overnight. The resulting mixture was poured into water (200 mL), washedwith sat. aq. Na2S2O3 (100 mL) and then extracted with ethyl acetate (3 x 150 mL). The combined organiclayers were washed with brine (100 mL), dried over Na2SO4, and concentrated. The crude material waspurified by flash chromatography (silica gel, 5–40percent EtOAc in hexanes) to give the desired product 6 (5.8 g,81percent). Physical State: light yellow oil; Rf = 0.55 (2:8 EtOAc/hexanes, vis. UV); 1H NMR (500 MHz, CDCl3): δ 4.67 –4.60 (m, 2H), 4.50 – 4.43 (m, 1H), 4.33 – 4.24 (m, 2H), 1.44 (s, 9H); 13C NMR (126 MHz, CDCl3): δ 155.7, 80.3,61.7 (br, 2C), 28.4 (3C), 2.7; HRMS (ESI-TOF): calc’d for C8H14INNaO2 [M+Na+] 305.9967; found 305.9950.
Reference: [1] Arkivoc, 2018, vol. 2018, # 4, p. 195 - 214
  • 7
  • [ 142253-55-2 ]
  • [ 254454-54-1 ]
YieldReaction ConditionsOperation in experiment
78% With 1,3-Diiodo-5,5-dimethyl-2,4-imidazolidinedione In 1,2-dichloro-ethane for 3 h; Reflux; Irradiation EXAMPLE 3; Radical iodo-de-caboxylation induced by TV-iodo amides/V-iodo amideR-COOH *- R-lGeneral procedure[00111] Procedure: A mixture of R-COOH (1 mmol), N-iodo amide (1-4 equiv), and solvent (3-6 mL) was refluxed (Δ) for 1-24 h in the dark (NL) or under irradiation with 500 W tungsten lamp (TL) or under fluorescent room lighting (FL).[00112] Treatment: The reaction mixture was cooled to rt, and washed with aq NaHS03 and NaHC03 to destroy excess of iodination agent and dissolve unreacted carboxylic acid. The organic solution was dried (Na2S04), filtered through short silica or alumina pad and concentrated in vacuo to give iodide R-I. 100113J Purification: Optionally, the iodide R-I was further purified by crystallization (if the iodide is crystalline compound), or rectification (if the iodide is liquid compound). Analytical sample of the product was purified by column chromatography./V-iodoamideAlk-COOH *- Alk-I[00114] A mixture of Alk-COOH (1 mmol), N-iodo amide (1-3 equiv), and solvent (4 mL) was refluxed (Δ) in the dark (NL) or under irradiation with 500 W tungsten lamp (TL), or under fluorescent room lighting (FL).
Reference: [1] Patent: WO2011/154953, 2011, A1, . Location in patent: Page/Page column 28-30
[2] Advanced Synthesis and Catalysis, 2011, vol. 353, # 9, p. 1438 - 1442
  • 8
  • [ 24424-99-5 ]
  • [ 254454-54-1 ]
Reference: [1] Synlett, 1998, # 4, p. 379 - 380
[2] Patent: WO2008/116831, 2008, A1,
  • 9
  • [ 773837-37-9 ]
  • [ 254454-54-1 ]
  • [ 142253-54-1 ]
YieldReaction ConditionsOperation in experiment
78% at 130℃; for 6 h; To a 100 mL round bottom flask was added tert-butyl 3-iodoazetidine-1-carboxylate (6) (6.54 g, 0.0231 mol, 1 equiv.) and DMSO (25 mL). NaCN (2.3 g, 0.0462 mol, 2equiv.) was added to the solution in one portion and stirred at 130 oC for 6 h. The resulting mixture was cooledto rt, poured into water (200 mL), and extracted with diethyl ether (5 x 200 mL). The combined organicextracts were washed with brine (50 mL), dried over Na2SO4 and concentrated. The crude compound waspurified by flash chromatography (silica gel, 5–50percent EtOAc in hexanes) to give the desired product 22 (3.27 g,78percent). Physical State: off-white solid (mp 78–80 oC); Rf = 0.40 (2:8 EtOAc/hexanes, vis. KMnO4); 1H NMR (500MHz, CDCl3): δ 4.23 – 4.11 (m, 4H), 3.38 (tt, J 8.9, 6.3 Hz, 1H), 1.43 (s, 9H); 13C NMR (126 MHz, CDCl3): δ 155.6,119.6, 80.8, 52.6 (br, 2C), 28.4 (3C), 17.2.
Reference: [1] Arkivoc, 2018, vol. 2018, # 4, p. 195 - 214
  • 10
  • [ 254454-54-1 ]
  • [ 142253-55-2 ]
Reference: [1] Arkivoc, 2018, vol. 2018, # 4, p. 195 - 214
  • 11
  • [ 254454-54-1 ]
  • [ 193269-78-2 ]
Reference: [1] Patent: US2001/21718, 2001, A1,
  • 12
  • [ 74-89-5 ]
  • [ 254454-54-1 ]
  • [ 454703-20-9 ]
Reference: [1] Patent: WO2004/96810, 2004, A1, . Location in patent: Page 172
  • 13
  • [ 269410-08-4 ]
  • [ 254454-54-1 ]
  • [ 877399-35-4 ]
Reference: [1] Patent: WO2016/134320, 2016, A1, . Location in patent: Page/Page column 116
  • 14
  • [ 636-98-6 ]
  • [ 254454-54-1 ]
  • [ 883901-62-0 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With chloro-trimethyl-silane; ethylene dibromide In tetrahydrofuran at 20 - 80℃; for 2.5 h; Inert atmosphere
Stage #2: With tris-(dibenzylideneacetone)dipalladium(0); trifuran-2-yl-phosphane In tetrahydrofuran at 55℃; for 3 h;
(a) tert-Butyl-3-(4-nitrophenyl) azetidine- 1-carboxylate (16)1,2-Dibromoethane (0.146 mL, 1.69 mmol) was added to a vigorously stirred suspension of zinc dust (0.901 g, 13.8 mmol) in THF (3.5 mL) under a nitrogen atmosphere and the resulting suspension heated at 80 00 for 10 minutes. Trimethylsilyl chloride (0.202 mL, 1.59 mmol) in THF (1.75 mL) was added at roomtemperature and after stirring for 4 minutes a solution of tert-butyl 3-iodoazetidine-1- carboxylate (3.00 g, 10.6 mmol) in THF (3.5 mL) was added dropwise over a period of 15 minutes. The resulting mixture was stirred at room temperature for 2 hours then Pd2(dba)3 (0.155 g, 0.170 mmol) and tri-2-furylphosphine (0.143 g, 0.615 mmol) were added followed by 1-iodo-4-nitrobenzene (2.90 g, 11.7 mmol) in THF (18 mL). Theresulting mixture was heated at 55 00 for 3 hours then quenched at room temperature with a saturated aqueous sodium chloride solution (15 mL). The aqueous phase was extracted with DCM (2 x 15 mL) then the combined organic fractions were dried (magnesium sulfate), filtered and evaporated in vacuo. The residue was purified using silica gel column chromatography (CombiFlash Rf, 40 gSi02 Cartridge, 10-40percent EtOAc in cyclohexane) to give the title compound 16 as anorange oil (2.14 g, 72percent); 1H NMR (300 MHz, CDCI3) O 8.24 (dd, J= 6.8, 1.9 Hz, 2H),7.51 (d, J= 8.6 Hz, 2H), 4.41 (t, J= 8.7 Hz, 2H), 3.98 (dd, J= 8.5, 5.7 Hz, 2H), 3.89-3.81 (5, 1H), 1.49 (5, 9H).
Reference: [1] Patent: WO2014/26243, 2014, A1, . Location in patent: Page/Page column 88
[2] Patent: WO2014/26242, 2014, A1, . Location in patent: Page/Page column 133; 134
  • 15
  • [ 254454-54-1 ]
  • [ 887591-62-0 ]
Reference: [1] Arkivoc, 2018, vol. 2018, # 4, p. 195 - 214
  • 16
  • [ 254454-54-1 ]
  • [ 287193-01-5 ]
Reference: [1] Organic Process Research and Development, 2018, vol. 22, # 10, p. 1409 - 1418
  • 17
  • [ 127-08-2 ]
  • [ 254454-54-1 ]
  • [ 1215205-53-0 ]
Reference: [1] Arkivoc, 2018, vol. 2018, # 4, p. 195 - 214
  • 18
  • [ 254454-54-1 ]
  • [ 916421-36-8 ]
Reference: [1] Patent: WO2014/26243, 2014, A1,
[2] Patent: WO2014/26242, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 254454-54-1 ]

Amides

Chemical Structure| 1234576-81-8

[ 1234576-81-8 ]

(S)-tert-Butyl 3-iodopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 1234576-86-3

[ 1234576-86-3 ]

(R)-tert-Butyl 3-iodopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 774234-25-2

[ 774234-25-2 ]

tert-Butyl 3-iodopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 147621-21-4

[ 147621-21-4 ]

tert-Butyl azetidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 850761-36-3

[ 850761-36-3 ]

tert-Butyl 3-iodopiperidine-1-carboxylate

Similarity: 0.84

Related Parent Nucleus of
[ 254454-54-1 ]

Aliphatic Heterocycles

Chemical Structure| 1234576-81-8

[ 1234576-81-8 ]

(S)-tert-Butyl 3-iodopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 1234576-86-3

[ 1234576-86-3 ]

(R)-tert-Butyl 3-iodopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 774234-25-2

[ 774234-25-2 ]

tert-Butyl 3-iodopyrrolidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 147621-21-4

[ 147621-21-4 ]

tert-Butyl azetidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 850761-36-3

[ 850761-36-3 ]

tert-Butyl 3-iodopiperidine-1-carboxylate

Similarity: 0.84

Azetidines

Chemical Structure| 147621-21-4

[ 147621-21-4 ]

tert-Butyl azetidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 325775-44-8

[ 325775-44-8 ]

tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate

Similarity: 0.82

Chemical Structure| 142253-56-3

[ 142253-56-3 ]

1-Boc-Azetidine-3-yl-methanol

Similarity: 0.80

Chemical Structure| 141699-55-0

[ 141699-55-0 ]

tert-Butyl 3-hydroxyazetidine-1-carboxylate

Similarity: 0.80

Chemical Structure| 1173206-71-7

[ 1173206-71-7 ]

tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride

Similarity: 0.80